{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:39:31Z","timestamp":1787312371429,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijantimicag.2026.107795","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:42:23Z","timestamp":1774885343000},"page":"107795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy, safety, and population pharmacokinetics of eravacycline for carbapenem-resistant organism infections in immunocompromised hosts: A multicenter prospective cohort study"],"prefix":"10.1016","volume":"67","author":[{"given":"Yifu","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangde","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiming","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1478-2395","authenticated-orcid":false,"given":"Lingai","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107795_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106331","article-title":"Clinical characteristics and prognosis of bloodstream infections with carbapenem-resistant gram-negative organisms in patients with hematological malignancies: a multicenter case-control study in China","volume":"89","author":"Zhou","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0002","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00134-023-07295-2","article-title":"ICU-acquired infections in immunocompromised patients","volume":"50","author":"Kreitmann","year":"2024","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.DMIH2-0003-2015","article-title":"Hospital-associated infections","volume":"4","author":"Babady","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0004","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00063-024-01168-2","article-title":"[Infections and liver cirrhosis","volume":"119","author":"Dibos","year":"2024","journal-title":"Med Klin Intensiv Notfmed"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijid.2017.06.023","article-title":"Bloodstream infections caused by acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors","volume":"62","author":"Park","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2025.107663","article-title":"Combined disk-based tests for phenotypic identification of KPC variants in enterobacterales","volume":"67","author":"Yang","year":"2026","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0007","article-title":"Emergence of resistance to novel \u03b2-lactam\/\u03b2-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae: clinical and genomic insights from consecutive bloodstream infections","author":"Boattini","year":"2025","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105328","article-title":"Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injury","volume":"163","author":"Sisay","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0009","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jinf.2022.03.010","article-title":"Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: a large multicentre case-control and cohort study","volume":"84","author":"Lou","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.mcna.2025.01.003","article-title":"Management of severe infections: multidrug-resistant and carbapenem-resistant gram-negative bacteria","volume":"109","author":"Perez","year":"2025","journal-title":"Med Clin N Am"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0011","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jointm.2023.12.007","article-title":"Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: a narrative review","volume":"4","author":"Roger","year":"2024","journal-title":"J Intensive Med"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0012","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40265-016-0545-8","article-title":"Review of Eravacycline, a novel fluorocycline antibacterial agent","volume":"76","author":"Zhanel","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0013","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s10096-019-03590-3","article-title":"Eravacycline, a newly approved fluorocycline","volume":"38","author":"Lee","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0014","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14787210.2024.2351552","article-title":"Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications","volume":"22","author":"Huang","year":"2024","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00565-25","article-title":"Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomes","volume":"13","author":"Kunz Coyne","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0016","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet (Lond Engl)"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0017","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00134-023-07295-2","article-title":"ICU-acquired infections in immunocompromised patients","volume":"50","author":"Kreitmann","year":"2024","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0018","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1600-6143.2009.02700.x","article-title":"Donor-derived disease transmission events in the United States: data reviewed by the OPTN\/UNOS disease transmission advisory committee","volume":"9","author":"Ison","year":"2009","journal-title":"Am J Transplant : Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0019","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/TP.0b013e318236cd02","article-title":"Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation","volume":"92","author":"Garzoni","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0020","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1186\/s12889-025-22065-z","article-title":"Determinants of dementia risk among older adults with probable sarcopenia and sarcopenia","volume":"25","author":"Lipoeto","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0021","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4143\/crt.2019.695","article-title":"Computed tomography-determined sarcopenia is a useful imaging biomarker for predicting postoperative outcomes in elderly colorectal cancer patients","volume":"52","author":"Xie","year":"2020","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0022","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00134-017-4947-1","article-title":"Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study","volume":"43","author":"Azoulay","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0332807","article-title":"Clinical characteristics, risk factors and outcome of critically ill immunocompromised patients with bloodstream infections and sepsis","volume":"20","author":"Vonineng","year":"2025","journal-title":"PloS One"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0024","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cmi.2023.11.008","article-title":"Attributable mortality of infections caused by carbapenem-resistant enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)","volume":"30","author":"Paniagua-Garc\u00eda","year":"2024","journal-title":"Clin Microbiol Infect : Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0025","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing enterobacteriaceae (INCREMENT): a retrospective cohort study","volume":"17","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0026","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13054-023-04792-0","article-title":"Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to gram-negative pathogens: a multicenter retrospective cohort study","volume":"28","author":"Barbier","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0027","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00134-019-05520-5","article-title":"Rationalizing antimicrobial therapy in the ICU: a narrative review","volume":"45","author":"Timsit","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0028","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamasurg.2016.4237","article-title":"Assessing the efficacy and safety of eravacycline vs ertapenem in complicated intra-abdominal infections in the investigating gram-negative infections treated with eravacycline (IGNITE 1) trial: a randomized clinical trial","volume":"152","author":"Solomkin","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0029","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/cid\/ciy1029","article-title":"IGNITE4: results of a phase 3, randomized, multicenter, prospective trial of eravacycline vs Meropenem in the treatment of complicated intraabdominal infections","volume":"69","author":"Solomkin","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0030","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10096-023-04616-7","article-title":"In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against acinetobacter baumannii causing bloodstream infections in Greece, 2020-2021: a multicenter study","volume":"42","author":"Galani","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0031","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1128\/AAC.00436-16","article-title":"In vitro activity of eravacycline against carbapenem-resistant enterobacteriaceae and acinetobacter baumannii","volume":"60","author":"Livermore","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0032","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40265-019-01117-w","article-title":"Correction to: eravacycline: a review in complicated intra-abdominal infections","volume":"79","author":"Scott","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0033","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/1120009X.2023.2213600","article-title":"Comparative in vitro activities of eravacycline in combination with colistin, meropenem, or ceftazidime against various achromobacter spp. Strains isolated from patients with cystic fibrosis","volume":"35","author":"\u00d6zer","year":"2023","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0034","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/14787210.2024.2397663","article-title":"Efficacy and safety of eravacycline (ERV) in treating infections caused by gram-negative pathogens: a systematic review and meta-analysis","volume":"22","author":"Chen","year":"2024","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0035","first-page":"43","article-title":"Lung transplantation\u2014indications, follow-up care and long-term results","volume":"122","author":"Michel","year":"2025","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0036","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.healun.2021.07.018","article-title":"The international thoracic organ transplant registry of the international society for heart and lung transplantation: twenty-fourth pediatric lung transplantation report - 2021; focus on recipient characteristics","volume":"40","author":"Hayes","year":"2021","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0037","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.healun.2020.07.010","article-title":"The international thoracic organ transplant registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics","volume":"39","author":"Khush","year":"2020","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0038","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1128\/AAC.02036-13","article-title":"Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women","volume":"58","author":"Connors","year":"2014","journal-title":"Antimicrob agents chemother"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0039","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0040","article-title":"Polymicrobial infections and biofilms: clinical significance and eradication strategies","volume":"11","author":"Anju","year":"2022","journal-title":"Antibiot (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0041","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.3748\/wjg.v23.i31.5809","article-title":"Donor-derived infections among Chinese donation after cardiac death liver recipients","volume":"23","author":"Ye","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0042","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12866-024-03343-z","article-title":"Effect of preservation fluid contamination and associated possible donor-derived infections on early postoperative prognosis in kidney transplant recipients","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0043","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ajt.2024.02.005","article-title":"Donor-derived carbapenem-resistant gram-negative bacterial infections in solid organ transplant recipients: active surveillance enhances recipient safety","volume":"24","author":"Mularoni","year":"2024","journal-title":"Am J Transpl"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0044","first-page":"321","article-title":"Assessing the impact of positive cultures in preservation fluid on renal transplant outcomes: a scoping review","volume":"38","author":"Machado","year":"2025","journal-title":"J Nephrol"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0045","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/cid\/ciu052","article-title":"The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies","volume":"58","author":"Satlin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106844","article-title":"Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials","volume":"62","author":"Chen","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0047","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13820","article-title":"Colistin sulfate for decontamination of preservation fluid in kidney transplantation to decrease the incidence of donor-derived infections caused by multidrug-resistant gram-negative bacteria","volume":"24","author":"Sui","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0048","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1056\/NEJMc2506050","article-title":"Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections","volume":"393","author":"Non","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146905","article-title":"Antibiotic therapy duration for multidrug-resistant gram-negative bacterial infections: an evidence-based review","volume":"26","author":"Marino","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3947\/ic.2024.0055","article-title":"Optimizing treatment for carbapenem-resistant Acinetobacter baumannii complex infections: a review of current evidence","volume":"56","author":"Choi","year":"2024","journal-title":"Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0051","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmi.2022.08.007","article-title":"Shorter antibiotic courses in the immunocompromised: the impossible dream?","volume":"29","author":"Imlay","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0052","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13518","article-title":"Effectiveness of short vs long-course perioperative antibiotics in lung transplant recipients with donor positive respiratory cultures","volume":"23","author":"Groff","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0053","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1526924820933824","article-title":"Duration of perioperative antimicrobial prophylaxis in orthotopic liver transplantation patients","volume":"30","author":"Bandali","year":"2020","journal-title":"Prog Transpl"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0054","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/lt.25486","article-title":"Intraoperative versus extended antibiotic prophylaxis in liver transplant surgery: a randomized controlled pilot trial","volume":"25","author":"Berry","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0055","doi-asserted-by":"crossref","first-page":"ofaf298","DOI":"10.1093\/ofid\/ofaf298","article-title":"Variability in durations of therapy for gram-negative bloodstream infections and factors associated with prolonged durations","volume":"12","author":"Sutton","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0056","article-title":"Some suggestions from PK\/PD principles to contain resistance in the clinical setting-focus on ICU patients and gram-negative strains","volume":"9","author":"Adembri","year":"2020","journal-title":"Antibiot (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0057","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26092671","article-title":"New antibiotics for multidrug-resistant bacterial strains: latest research developments and future perspectives","volume":"26","author":"Terreni","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0058","article-title":"Population pharmacokinetics and pulmonary modeling of eravacycline and the determination of microbiological breakpoint and cutoff of PK\/PD","volume":"69","author":"Xw","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0059","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00250-17","article-title":"Vivo pharmacodynamic target assessment of eravacycline against Escherichia coli in a Murine thigh infection model","volume":"61","author":"Zhao","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0060","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s40262-019-00767-z","article-title":"Clinical pharmacokinetics and pharmacodynamics of eravacycline","volume":"58","author":"McCarthy","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0061","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00003495-200059020-00021","article-title":"Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation","volume":"59","author":"Plosker","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0062","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases","volume":"13","author":"Munoz-Price","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107795_bib0063","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02260-23","article-title":"A global view on carbapenem-resistant acinetobacter baumannii","volume":"14","author":"M\u00fcller","year":"2023","journal-title":"mBio"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T19:04:19Z","timestamp":1779735859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0924857926000841"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107795","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety, and population pharmacokinetics of eravacycline for carbapenem-resistant organism infections in immunocompromised hosts: A multicenter prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107795","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107795"}}